Title of article
Predictors of death or myocardial infarction during follow-up after coronary stenting with the sirolimus-eluting stent. Results from the prospective multicenter German Cypher Stent Registry
Author/Authors
Ralf Zahn، نويسنده , , Christian W. Hamm، نويسنده , , Steffen Schneider، نويسنده , , Uwe Zeymer and PENTUA Investigators، نويسنده , , Gert Richardt، نويسنده , , Malte Kelm، نويسنده , , Benny Levenson، نويسنده , , Tassilo Bonzel، نويسنده , , Ulrich Tebbe، نويسنده , , Georg Sabin، نويسنده , , Christoph A. Nienaber، نويسنده , , Jochen Senges and for the German Cypher Stent Registry، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2006
Pages
7
From page
1146
To page
1152
Abstract
Background
Drug-eluting coronary stents are the most recent “breakthrough” technology in interventional cardiology. Whereas risk factors influencing restenosis and need for target vessel revascularization are well known, risk factors for dying or developing a myocardial infarction (MI) after drug-eluting coronary stent implantation need to be evaluated yet.
Methods
We evaluated data from the German Cypher Stent Registry.
Results
From April 2002 to December 2004, 7445 patients at 122 hospitals, who received at least one sirolimus-eluting stent during percutaneous coronary intervention, were included. Complete follow-up at a median of 6.6 months (quartiles 6.1-8.1 months) was available in 6755 patients (91%). Death occurred in 1.8% (120/6755) of patients, nonfatal MI in 2.3% (156/6635), and death or MI in 4.1% (276/6755) of patients. Independent predictors of death or MI were initial presentation with ST-elevation MI or non–ST-elevation MI (OR [odds ratio] 2.21, 95% CI 1.66-2.95, P < .0001), cardiogenic shock (OR 3.05, 95% CI 1.67-5.55, P = .0003), renal insufficiency (OR 1.74, 95% CI 1.24-2.44, P = .0017), reduced left ventricular function (OR 1.74, 95% CI 1.21-2.50, P = .0027), age (per decade) (OR 1.19, 95% CI 1.05-1.36, P = .0058), diabetes mellitus (OR 1.39, 95% CI 1.05-1.84, P = .0183), 3-vessel disease (OR 1.32, 95% CI 0.99-1.77, P = .043), and prior MI (OR 1.35, 95% CI 1.01-1.80, P = .0468), whereas interventional and lesion characteristics showed no significant association.
Conclusions
These results demonstrate that the most powerful predictors of death or MI after sirolimus-eluting stent implantation during percutaneous coronary intervention are presentation with an acute coronary syndrome, impaired left ventricular ejection fraction, and conventional risk factors for coronary heart disease. Interventional and lesion characteristics do not play a major role.
Journal title
American Heart Journal
Serial Year
2006
Journal title
American Heart Journal
Record number
534701
Link To Document